다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Antiviral research, v.113, 2015년, pp.93 - 102
Ezzikouri, S. , Nishimura, T. , Kohara, M. , Benjelloun, S. , Kino, Y. , Inoue, K. , Matsumori, A. , Tsukiyama-Kohara, K.
AI-Helper
Chronic hepatitis C virus (HCV) infection increases the risk of liver cirrhosis and hepatocellular carcinoma. In the last decade, the current standard HCV treatment, pegylated interferon and ribavirin, have limited efficacy and significant side effects. Novel direct acting antivirals show promise, b...
American Botanical Council, 2010. Scientific and clinical monograph for Pycnogenol.
Liver Int. Antaki 30 342 2010 10.1111/j.1478-3231.2009.02188.x The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report
N. Engl. J. Med. Bacon 364 1207 2011 10.1056/NEJMoa1009482 Boceprevir for previously treated chronic HCV genotype 1 infection
Antivir. Chem. Chemother. Bassit 19 25 2008 10.1177/095632020801900104 Combinations of 2′-C-methylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon system
J. Virol. Blight 76 13001 2002 10.1128/JVI.76.24.13001-13014.2002 Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication
Toxicol. Appl. Pharmacol. Cho 168 64 2000 10.1006/taap.2000.9001 Effect of bioflavonoids extracted from the bark of Pinus maritima on proinflammatory cytokine interleukin-1 production in lipopolysaccharide-stimulated RAW 264.7
Phytother. Res. Choi 23 1691 2009 10.1002/ptr.2812 Pycnogenol inhibits immunoglobulin E-mediated allergic response in mast cells
Adv. Enzyme Regul. Chou 22 27 1984 10.1016/0065-2571(84)90007-4 Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
Hepatology de Mochel 52 47 2010 10.1002/hep.23671 Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection
Jpn. J. Infect. Dis. Feng 61 279 2008 10.7883/yoken.JJID.2008.279 Pycnogenol, a procyanidin-rich extract from French maritime pine, inhibits intracellular replication of HIV-1 as well as its binding to host cells
Proc. Natl. Acad. Sci. U.S.A. Gong 98 9599 2001 10.1073/pnas.171311298 Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B
N. Engl. J. Med. Hoofnagle 355 2444 2006 10.1056/NEJMct061675 Peginterferon and ribavirin for chronic hepatitis C
Hepatology Inoue 45 921 2007 10.1002/hep.21587 Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo
N. Engl. J. Med. Jacobson 364 2405 2011 10.1056/NEJMoa1012912 Telaprevir for previously untreated chronic hepatitis C virus infection
Gastroenterology Katsume 145 865 2013 10.1053/j.gastro.2013.06.012 A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes
Viruses Ke 4 2251 2012 10.3390/v4102251 Hepatitis C virus and cellular stress response: implications to molecular pathogenesis of liver diseases
Virology Khachatoorian 433 346 2012 10.1016/j.virol.2012.08.029 Divergent antiviral effects of bioflavonoids on the hepatitis C virus life cycle
N. Engl. J. Med. Lawitz 368 1878 2013 10.1056/NEJMoa1214853 Sofosbuvir for previously untreated chronic hepatitis C infection
Phytother. Res. Lee 24 1242 2010 10.1002/ptr.3193 Effect of pycnogenol on glucose transport in mature 3T3-L1 adipocytes
J. Transl. Med. Levent 4 25 2006 10.1186/1479-5876-4-25 Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy
Antivir. Chem. Chemother. Li 20 239 2010 10.3851/IMP1597 Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication
PLoS ONE Lin 8 e54466 2013 10.1371/journal.pone.0054466 Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation
J. Ethnopharmacol. Maimoona 133 261 2011 10.1016/j.jep.2010.10.041 A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract
J. Card. Fail. Matsumori 13 785 2007 10.1016/j.cardfail.2007.06.721 French maritime pine bark extract inhibits viral replication and prevents development of viral myocarditis
Nat. Med. Mercer 7 927 2001 10.1038/90968 Hepatitis C virus replication in mice with chimeric human livers
Hepatology Mohd Hanafiah 57 1333 2013 10.1002/hep.26141 Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence
J. Biol. Chem. Nishimura 284 36442 2009 10.1074/jbc.M109.043232 Hepatitis C virus impairs p53 via persistent overexpression of 3beta-hydroxysterol Delta24-reductase
J. Gastroenterol. Ozeki 46 929 2011 10.1007/s00535-011-0411-0 Antiviral effects of peginterferon alpha-2b and ribavirin following 24-week monotherapy of telaprevir in Japanese hepatitis C patients
Free Radic. Biol. Med. Packer 27 704 1999 10.1016/S0891-5849(99)00090-8 Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol
J. Hepatol. Perz 44 441 2006 10.1016/j.jhep.2005.12.007 The coming wave of HCV-related liver disease: dilemmas and challenges
N. Engl. J. Med. Poordad 364 1195 2011 10.1056/NEJMoa1010494 Boceprevir for untreated chronic HCV genotype 1 infection
Antiviral Res. Poveda 108 181 2014 10.1016/j.antiviral.2014.05.015 Update on hepatitis C virus resistance to direct-acting antiviral agents
Int. J. Biochem. Cell Biol. Quarato 45 156 2013 10.1016/j.biocel.2012.06.008 Targeting mitochondria in the infection strategy of the hepatitis C virus
Nat. Chem. Biol. Sakamoto 1 333 2005 10.1038/nchembio742 Host sphingolipid biosynthesis as a target for hepatitis C virus therapy
Can. J. Gastroenterol. Serejo 17 644 2003 10.1155/2003/710693 Oxidative stress in chronic hepatitis C: the effect of interferon therapy and correlation with pathological features
PLoS ONE Shen 8 e82299 2013 10.1371/journal.pone.0082299 Inhibitory effects of caffeic acid phenethyl ester derivatives on replication of hepatitis C virus
J. Hepatol. Takano 55 512 2011 10.1016/j.jhep.2010.12.011 Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes
Gastroenterology Takeuchi 116 636 1999 10.1016/S0016-5085(99)70185-X Real-time detection system for quantification of hepatitis C virus genome
Trends Microbiol. Tardif 13 159 2005 10.1016/j.tim.2005.02.004 Hepatitis C virus, ER stress, and oxidative stress
Am. J. Pathol. Tateno 165 901 2004 10.1016/S0002-9440(10)63352-4 Near completely humanized liver in mice shows human-type metabolic responses to drugs
Nat. Med. Thomas 19 850 2013 10.1038/nm.3184 Global control of hepatitis C: where challenge meets opportunity
Free Radic. Res. Voss 40 673 2006 10.1080/10715760500419357 Ferritin oxidation and proteasomal degradation: protection by antioxidants
Nat. Med. Wakita 11 791 2005 10.1038/nm1268 Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
J. Biol. Chem. Waris 278 40778 2003 10.1074/jbc.M303248200 Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease
J. Virol. Waris 79 1569 2005 10.1128/JVI.79.3.1569-1580.2005 Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication
Gene Ther. Watanabe 13 883 2006 10.1038/sj.gt.3302734 Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype
Nutr. Res. Zibadi 28 315 2008 10.1016/j.nutres.2008.03.003 Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.